Chronic Glaucoma

Chronic glaucoma is a progressive ocular condition in dogs characterized by persistently elevated intraocular pressure that develops gradually over time and causes cumulative damage to the optic nerve and retinal structures. Unlike acute glaucoma, which presents as a sudden emergency, chronic glaucoma develops insidiously and may go undetected until significant vision loss has already occurred. This condition represents one of the leading causes of blindness in dogs and affects thousands of canines each year across all breeds, though certain breeds demonstrate significantly higher prevalence rates due to inherited anatomical predispositions.

The underlying mechanism of chronic glaucoma involves impaired drainage of aqueous humor, the clear fluid that normally circulates within the eye to maintain proper pressure and nourish internal structures. When the drainage angle or trabecular meshwork becomes progressively compromised, fluid accumulates faster than it can exit the eye, leading to sustained pressure elevation. This persistent pressure damages the delicate nerve fibers of the optic nerve and compromises blood flow to the retina, resulting in gradual and often irreversible vision deterioration. The chronic nature of this condition means that damage accumulates over weeks, months, or even years before clinical signs become apparent to owners.

Chronic glaucoma significantly impacts affected dogs' quality of life as vision progressively declines. Dogs may initially compensate well for early vision loss, particularly when only one eye is affected, making detection challenging without regular veterinary eye examinations. As the condition progresses, dogs experience increasing visual impairment that affects their ability to navigate familiar environments, interact with family members, and engage in normal activities. The condition can also cause chronic discomfort ranging from mild headache-like sensations to significant ocular pain, though dogs often mask these symptoms effectively.

While chronic glaucoma cannot be cured, early detection and aggressive management can significantly slow disease progression and preserve remaining vision for extended periods. Treatment typically involves a combination of topical medications to reduce fluid production and enhance drainage, along with regular monitoring of intraocular pressure. In cases where medical management proves insufficient, various surgical options exist to improve fluid drainage or reduce fluid production. The importance of early detection cannot be overstated, as treatment initiated before significant optic nerve damage occurs yields substantially better outcomes than intervention after vision loss has become apparent.

The primary cause of chronic glaucoma in dogs involves dysfunction of the eye's aqueous humor drainage system, which maintains proper intraocular pressure through a delicate balance between fluid production and outflow. The ciliary body continuously produces aqueous humor, which flows through the pupil into the anterior chamber and exits through the drainage angle at the junction of the iris and cornea. When this drainage pathway becomes progressively obstructed or dysfunctional, pressure builds gradually within the eye. The chronic nature of this buildup distinguishes this form from acute glaucoma, where drainage failure occurs suddenly and dramatically.

Genetic and hereditary factors play a substantial role in the development of chronic glaucoma in many dogs. Certain breeds inherit anatomical abnormalities of the drainage angle, known as goniodysgenesis, which predispose them to impaired outflow throughout their lives. These inherited malformations may not cause problems in young dogs but become increasingly significant as age-related changes compound the existing drainage limitations. The genetic basis of primary glaucoma means that affected dogs should not be bred, and relatives of affected animals should undergo screening examinations to detect predisposition before clinical disease develops.

Environmental and lifestyle factors, while less significant than genetics in primary chronic glaucoma, can influence disease development and progression. Chronic inflammation within the eye from any cause can damage drainage structures over time, leading to secondary chronic glaucoma. Conditions such as uveitis, lens luxation, or intraocular tumors may initially cause acute pressure spikes but can evolve into chronic glaucoma if the underlying damage persists. Additionally, previous eye injuries or surgeries may compromise drainage function and establish conditions for chronic pressure elevation.

Age represents a significant risk factor for chronic glaucoma development, as drainage efficiency naturally decreases over time even in anatomically normal eyes. The trabecular meshwork, the primary drainage structure, becomes less permeable with age due to cellular changes and debris accumulation. When age-related decline combines with pre-existing anatomical limitations or previous subclinical damage, the threshold for maintaining normal pressure may be exceeded, initiating chronic glaucoma. This explains why many dogs develop clinical glaucoma in middle to older age despite having inherited predisposition from birth.

The mechanism of damage in chronic glaucoma involves both mechanical and vascular components that work together to destroy the optic nerve. Elevated pressure directly compresses nerve fibers at the optic nerve head, disrupting axonal transport and cellular function. Simultaneously, increased pressure compromises blood flow through the delicate vessels supplying the optic nerve and retina, creating ischemic damage that compounds mechanical injury. The gradual nature of chronic glaucoma means this damage accumulates progressively, with each increment of pressure and each period of compromised circulation adding to the cumulative injury that eventually manifests as measurable vision loss.

Early warning signs of chronic glaucoma are notoriously subtle and frequently overlooked by even attentive dog owners. Unlike the dramatic presentation of acute glaucoma, chronic glaucoma develops so gradually that dogs have time to adapt to progressive vision changes. Initial symptoms may include slight changes in how a dog navigates in dim lighting conditions, hesitation when approaching stairs or unfamiliar obstacles, or subtle alterations in eye appearance that develop so slowly they escape notice. Many owners report in retrospect that their dog seemed slightly less confident in certain situations months before diagnosis, but these changes were attributed to aging or other factors.

Common symptoms that become apparent as chronic glaucoma progresses include visible enlargement of the affected eye, known as buphthalmos or buphthalmic eye. This enlargement occurs because sustained pressure stretches the elastic tissues of the eye, particularly in younger dogs whose sclera remains more pliable. The enlargement may be subtle initially but becomes increasingly noticeable as the condition advances. Additionally, owners may notice a hazy or cloudy appearance to the cornea, which develops as fluid is forced into corneal tissues under pressure. This cloudiness may fluctuate, appearing worse at certain times and clearing partially at others.

Behavioral changes often provide the first clues that a dog's vision is deteriorating due to chronic glaucoma. Affected dogs may become reluctant to venture into unfamiliar environments or may startle more easily when approached from the side of the affected eye. Changes in play behavior are common, with dogs showing less interest in catching toys or following moving objects. Some dogs become more clingy or anxious, seeking reassurance from their owners as their visual world becomes increasingly limited. Nighttime navigation often deteriorates before daytime vision, as the compromised eye has reduced ability to adapt to low-light conditions.

Physical examination signs visible to owners include changes in pupil size and reactivity, with the affected eye often showing a dilated pupil that responds sluggishly or incompletely to light. The eye may develop increased redness due to congestion of surface blood vessels attempting to drain against elevated pressure. In advanced cases, the lens may become visibly displaced from its normal position, and the surface of the eye may show a stretched, thinned appearance. Some dogs develop visible differences in eye size between the affected and unaffected eye, making asymmetry apparent even to casual observation.

Symptom progression in chronic glaucoma follows a variable but generally predictable pattern as damage accumulates. Initially, dogs may show only subtle visual field deficits, missing objects in their peripheral vision while central vision remains intact. As the optic nerve sustains further damage, visual field loss expands and central vision begins to deteriorate. Dogs may bump into objects on the affected side, misjudge distances when attempting to grab treats, or fail to notice familiar people approaching from certain angles. Without treatment, progression continues until functional blindness occurs in the affected eye, typically over months to years depending on the severity of pressure elevation.

Emergency symptoms requiring immediate veterinary attention can develop even in dogs with established chronic glaucoma when acute pressure spikes occur superimposed on chronic elevation. Signs of acute decompensation include sudden severe redness, intense cloudiness of the cornea, obvious pain indicated by squinting, pawing at the eye, or reluctance to be touched near the head, and visible eye enlargement that develops over hours rather than weeks. These acute episodes represent emergencies because the extremely high pressures associated with acute spikes can destroy remaining vision within hours. Any sudden worsening of symptoms in a dog with chronic glaucoma warrants same-day veterinary evaluation, as prompt pressure reduction may preserve vision that would otherwise be permanently lost.

Initial veterinary examination for suspected chronic glaucoma begins with a thorough history and comprehensive eye evaluation. The veterinarian will inquire about the duration and progression of any visual changes, previous eye problems or injuries, breed background, and family history of eye disease if known. Physical examination includes assessment of overall eye appearance, pupil size and symmetry, corneal clarity, and the presence of any visible abnormalities. The veterinarian will also evaluate the dog's vision through observing navigation in the exam room, menace response testing, and tracking moving objects. This initial assessment helps establish the clinical picture and guides subsequent diagnostic testing.

The definitive diagnostic test for glaucoma is tonometry, which measures intraocular pressure using specialized instruments. The most accurate method, applanation tonometry using devices such as the Tono-Pen or TonoVet, measures the force required to flatten a small area of the cornea, which correlates directly with internal eye pressure. Normal canine intraocular pressure ranges from approximately 10 to 25 mmHg, though normal values vary somewhat between instruments and individual dogs. In chronic glaucoma, pressures are typically elevated above 25-30 mmHg, though the degree of elevation may be less dramatic than in acute glaucoma due to chronic stretching of ocular tissues. Serial measurements over time help distinguish sustained elevation from temporary fluctuations.

Gonioscopy, a specialized examination of the drainage angle, provides crucial information about the underlying cause and prognosis of chronic glaucoma. Using a specialized lens placed on the corneal surface, the veterinary ophthalmologist can directly visualize the iridocorneal angle where aqueous humor drainage occurs. This examination reveals whether the drainage angle is open, narrowed, or closed, and whether abnormalities consistent with inherited goniodysgenesis are present. Gonioscopy findings help differentiate primary glaucoma from secondary causes and provide prognostic information about the fellow eye's risk when only one eye is currently affected.

Additional diagnostic testing helps characterize the extent of damage and identify any underlying causes contributing to chronic glaucoma. Fundoscopic examination evaluates the optic nerve head and retina for signs of glaucomatous damage, including optic nerve cupping, retinal vessel attenuation, and generalized retinal degeneration. Electroretinography may be performed to assess retinal function objectively, which helps determine prognosis and guides treatment decisions. If secondary glaucoma is suspected, additional testing such as ocular ultrasound may identify underlying causes like lens displacement, intraocular tumors, or chronic inflammation. Imaging studies help create a complete picture of the eye's condition and establish baselines for monitoring treatment response and disease progression.

Emergency treatment for acute pressure spikes in dogs with chronic glaucoma focuses on rapid pressure reduction to prevent additional irreversible damage. Intravenous mannitol, an osmotic diuretic, draws fluid from the eye into the bloodstream and can dramatically lower pressure within hours. Topical and systemic carbonic anhydrase inhibitors reduce aqueous humor production, while prostaglandin analogs enhance outflow through alternative pathways. These intensive measures are typically administered in a veterinary hospital setting with close monitoring until pressure stabilizes. Once acute elevation is controlled, attention shifts to establishing a long-term management protocol to prevent future crises.

Medical management forms the foundation of chronic glaucoma treatment and typically involves multiple topical medications applied to the affected eye several times daily. Prostaglandin analogs such as latanoprost or travoprost increase aqueous outflow through the uveoscleral pathway and represent first-line therapy for many patients. Carbonic anhydrase inhibitors like dorzolamide reduce aqueous production by the ciliary body. Beta-blockers such as timolol also decrease fluid production and may be used in combination with other agents. Most dogs with chronic glaucoma require multiple medications used together to achieve adequate pressure control, and owners must commit to consistent administration schedules for optimal outcomes.

Surgical intervention becomes necessary when medical therapy fails to adequately control pressure or when medication requirements become unsustainable. Cyclophotocoagulation uses laser energy to destroy portions of the ciliary body, reducing aqueous humor production at its source. This procedure can be performed either externally through the sclera or internally using an endoscope, with each approach having specific advantages depending on the individual case. Gonioimplant surgery places a small drainage device that shunts aqueous humor from inside the eye to a reservoir under the conjunctiva, bypassing the dysfunctional natural drainage system. These surgical options can provide lasting pressure reduction when successful but carry risks including inflammation, infection, and the potential need for repeat procedures.

Supportive care plays an essential role in comprehensive chronic glaucoma management and addresses comfort, quality of life, and overall eye health. Anti-inflammatory medications help control the chronic low-grade inflammation that often accompanies glaucoma and contributes to ongoing damage. Pain management is important because chronic pressure elevation causes discomfort that dogs may not obviously display. Lubricating eye drops help maintain corneal health, particularly in eyes with reduced blink reflexes or corneal exposure due to enlargement. Protecting affected eyes from trauma becomes increasingly important as the stretched sclera becomes more vulnerable to injury.

Alternative and complementary treatments may provide additional support alongside conventional therapy, though their effectiveness specifically for glaucoma control remains limited. Physical therapy and massage may help reduce stress and promote overall well-being, which indirectly supports treatment compliance. Some owners explore nutritional supplements with antioxidant properties, though evidence for direct benefit in canine glaucoma is lacking. Acupuncture has been used in some cases, primarily for pain management rather than pressure control. These approaches should be viewed as potential complements to, rather than replacements for, proven medical and surgical treatments.

Treatment decisions in chronic glaucoma involve careful consideration of multiple factors including disease severity, visual potential, patient comfort, owner capabilities, and financial constraints. Eyes with substantial remaining vision warrant aggressive treatment to preserve that vision as long as possible. However, when an eye has become blind and painful, enucleation (surgical removal) may provide the best quality of life outcome by eliminating chronic discomfort. The goals of treatment should be clearly established through honest discussions between the veterinary team and owners, with regular reassessment as the condition evolves. Success is measured not only by pressure control but by maintenance of comfort and quality of life for the affected dog.

Recovery timeline following treatment for chronic glaucoma varies substantially depending on the type of intervention and the condition of the eye at the time of treatment. Dogs initiating medical management may show stabilization of pressure within days to weeks, though finding the optimal medication combination often requires adjustment over several months. Following surgical procedures such as cyclophotocoagulation or gonioimplant placement, initial recovery typically spans two to four weeks during which inflammation subsides and the eye adjusts to its new dynamics. However, true assessment of surgical success requires monitoring over months, as late complications or treatment failure may not become apparent immediately.

Post-treatment care requirements depend on the specific treatment approach but universally involve close monitoring and strict medication compliance. Following initiation or adjustment of medical therapy, pressure checks should occur weekly initially, then extend to monthly and eventually quarterly as stability is confirmed. After surgical procedures, more intensive monitoring is required, with frequent rechecks during the first month and gradual spacing as healing progresses. Owners must master proper medication administration technique and maintain consistent dosing schedules, as missed doses can allow pressure spikes that erode previous gains. Activity restriction may be necessary following surgery, typically involving leash walks only and prevention of rough play during initial healing.

Prognosis factors in chronic glaucoma include the extent of existing damage at diagnosis, response to treatment, consistency of pressure control, and the underlying cause. Dogs diagnosed early with mild to moderate damage and good treatment response may maintain useful vision for years. However, those with advanced damage at presentation or poor pressure control face more guarded prognoses for vision preservation. The condition of the fellow eye significantly impacts overall prognosis, as primary glaucoma typically affects both eyes eventually. Studies suggest that once one eye develops primary glaucoma, the second eye has a 50% chance of developing the condition within one to two years without prophylactic treatment.

Long-term outlook for dogs with chronic glaucoma requires acceptance that this is a progressive condition requiring lifelong management rather than a curable disease. Even with optimal treatment, many affected eyes eventually lose functional vision as cumulative damage exceeds the optic nerve's capacity to transmit visual information. However, the rate of progression can be dramatically slowed with appropriate therapy, potentially adding years of useful vision compared to untreated disease. Dogs that do become blind often adapt remarkably well, particularly when vision loss occurs gradually and they have time to develop compensatory strategies. Ongoing veterinary care remains essential throughout the dog's life, with regular monitoring allowing early detection of treatment failure and timely adjustment of the management plan.

Primary prevention of chronic glaucoma centers on responsible breeding practices and early identification of at-risk individuals. Dogs diagnosed with primary glaucoma should never be bred, as they will pass genetic predisposition to offspring. Gonioscopy screening of breeding dogs in predisposed breeds allows identification of goniodysgenesis before clinical disease develops, enabling informed breeding decisions that can reduce glaucoma incidence over generations. Breed clubs for commonly affected breeds often maintain registries of eye examination results, and selecting breeding pairs with normal gonioscopy findings on both sides reduces the risk of producing affected puppies.

Breeding and genetic prevention strategies extend beyond the affected individual to their relatives. Parents, siblings, and offspring of dogs diagnosed with primary glaucoma should all be considered at elevated risk and monitored appropriately. Genetic counseling from veterinary ophthalmologists can help breeders understand inheritance patterns and make informed decisions about breeding programs. While genetic testing for glaucoma susceptibility genes is not yet widely available for most breeds, ongoing research aims to identify specific mutations that could enable DNA-based screening in the future. Supporting such research through participation in studies and breed health surveys advances prevention efforts for future generations.

Nutritional considerations for glaucoma prevention remain an area of active investigation, though specific dietary interventions proven to prevent the condition have not been established. Maintaining healthy body weight reduces overall metabolic stress and supports cardiovascular health, which may indirectly benefit ocular circulation. Antioxidant-rich diets may theoretically support nerve tissue health, though direct evidence for glaucoma prevention is lacking. Avoiding nutritional deficiencies that could compromise overall health ensures that dogs' bodies are best positioned to resist disease development. Owners of predisposed breeds should discuss any specific dietary recommendations with their veterinarians.

Health maintenance through regular veterinary care provides the foundation for early detection if glaucoma does develop. Annual comprehensive eye examinations are recommended for all dogs, with more frequent examinations for breeds at increased risk. Tonometry screening can detect elevated pressure before obvious clinical signs develop, enabling earlier intervention. For dogs in high-risk categories, baseline gonioscopy establishes their individual risk profile and guides monitoring intensity. Regular examinations also allow detection and treatment of conditions that could lead to secondary glaucoma, such as cataracts, uveitis, or lens instability.

Early intervention when the fellow eye of a dog with unilateral glaucoma remains normal can significantly delay or potentially prevent disease development. Prophylactic treatment with pressure-lowering medications has been shown to extend the time before the second eye develops clinical glaucoma. Regular tonometry monitoring of the unaffected eye allows detection of pressure increases before they reach damaging levels. Some veterinary ophthalmologists recommend prophylactic laser treatment to enhance drainage in eyes at high risk based on gonioscopy findings. Working closely with a veterinary ophthalmologist to implement an appropriate prevention protocol for the fellow eye represents one of the most impactful interventions available for dogs already diagnosed with unilateral primary glaucoma.

Daily management of a dog with chronic glaucoma centers on consistent medication administration and ongoing monitoring for changes in condition. Most dogs require multiple eye drops administered two to four times daily, necessitating a reliable routine that accommodates both the dog's and owner's schedules. Proper technique is essential for medication effectiveness, including allowing adequate time between different drops, ensuring the medication actually enters the eye, and avoiding contamination of the dropper tip. Keeping a log of medication times helps ensure consistency and provides valuable information for veterinary appointments. Many owners find it helpful to associate medication times with regular activities such as meals or daily walks.

Home environment modifications can significantly improve quality of life for dogs experiencing vision loss from chronic glaucoma. Maintaining consistent furniture arrangements helps visually impaired dogs navigate confidently using spatial memory. Blocking access to stairs or other hazards when the dog is unsupervised prevents accidents, and baby gates can define safe zones. Providing night lights helps dogs with partial vision navigate in dim conditions. Avoiding moving food and water bowls maintains predictability, and using textured mats or rugs to define important locations provides tactile navigation cues. Outdoor areas should be safely enclosed, and new environments should be introduced gradually with close supervision.

Quality of life for dogs with chronic glaucoma can remain excellent with appropriate adjustments and owner commitment. Many dogs adapt remarkably well to gradual vision loss, relying increasingly on their superior senses of smell and hearing. Maintaining normal activities to the extent possible supports psychological well-being, and most dogs can continue to enjoy walks, playtime, and social interaction. Using verbal cues and consistent commands helps communicate with visually impaired dogs. Scented toys and treat-dispensing puzzles provide mental stimulation that doesn't require vision. The bond between owner and dog often strengthens as they develop new ways of communicating and interacting.

Monitoring and ongoing veterinary care remain essential throughout the course of chronic glaucoma management. Owners should learn to recognize signs of pressure spikes or treatment failure, including increased cloudiness, redness, squinting, or apparent discomfort. Any sudden changes warrant prompt veterinary evaluation, as acute pressure elevation can occur superimposed on chronic disease. Regular scheduled rechecks, typically every three to four months for stable patients, allow pressure monitoring and treatment adjustment. Owners should communicate openly about their observations, concerns, and any difficulties with the treatment regimen, as alternative approaches may be available.

Caregiver support is important because managing a dog with chronic glaucoma requires significant time, emotional energy, and financial resources over an extended period. Connecting with online communities of owners facing similar challenges provides emotional support and practical tips. Understanding that treatment goals focus on comfort and quality of life rather than cure helps set realistic expectations. Planning for the financial aspects of long-term care, including emergency funds for acute crises, reduces stress when decisions must be made quickly. Veterinary social workers or counselors can help owners process the emotional aspects of caring for a chronically ill pet and making difficult decisions about treatment intensity and end-of-life care when that time comes.

High-risk breeds for chronic glaucoma include several that demonstrate inherited predisposition to goniodysgenesis and primary open-angle or closed-angle glaucoma. Cocker Spaniels, both American and English varieties, show particularly high prevalence rates and typically develop the condition in middle age. Basset Hounds inherit goniodysgenesis at very high rates and commonly develop glaucoma between four and eight years of age. Siberian Huskies and other Arctic breeds demonstrate increased susceptibility related to their ocular anatomy. Beagles, despite being generally healthy dogs, show elevated glaucoma rates compared to mixed-breed populations. Shar Peis, with their distinctive facial structure, experience both primary glaucoma and secondary glaucoma from breed-related eye conditions at increased frequency.

Moderate-risk breeds and categories include many purebred dogs that show elevated incidence compared to mixed-breed populations. Terrier breeds as a group demonstrate increased susceptibility, with Cairn Terriers, Wire Fox Terriers, and Scottish Terriers among those most frequently affected. Spaniels beyond Cockers, including English Springer Spaniels and Welsh Springer Spaniels, also show elevated risk. Toy breeds including Chihuahuas, Shih Tzus, and Poodles experience glaucoma more frequently than their small size might suggest. Giant breeds including Great Danes show increased risk, possibly related to the anatomical challenges of their large eyes. Mixed-breed dogs with ancestry from high-risk breeds may inherit predisposition, making family history relevant even for non-purebred dogs.

Screening recommendations for breeds at risk emphasize early and regular evaluation by veterinary ophthalmologists. The Canine Eye Registration Foundation (CERF) and Orthopedic Foundation for Animals (OFA) maintain databases of eye examination results that help track breed-wide prevalence and identify individual dogs suitable for breeding. For high-risk breeds, baseline gonioscopy examination is recommended by two years of age and before breeding. Annual eye examinations including tonometry should continue throughout life, with increased frequency for dogs showing any early abnormalities. Dogs from lines with known glaucoma history warrant particularly close monitoring. Working with breeders who prioritize eye health and can provide documentation of parental eye examinations helps prospective owners select puppies with reduced risk.

Commonly co-occurring conditions with chronic glaucoma include other ocular diseases that may share underlying causes or result from prolonged pressure elevation. Cataracts frequently develop in eyes with chronic glaucoma, either as a separate age-related or breed-related condition or as a consequence of chronic intraocular inflammation and metabolic changes associated with elevated pressure. Lens luxation, where the lens displaces from its normal position, can both cause and result from glaucoma, creating a cycle of increasing pressure and progressive damage. Retinal degeneration beyond that directly caused by glaucomatous damage may occur concurrently, particularly in breeds predisposed to both conditions. Managing dogs with multiple ocular conditions requires careful coordination of treatments and prioritization based on which conditions most impact vision and comfort.

Conditions with similar symptoms to chronic glaucoma must be considered during diagnostic evaluation to ensure accurate diagnosis and appropriate treatment. Anterior uveitis, inflammation within the eye, can cause redness, cloudiness, and discomfort that mimics glaucoma, though pressure is typically low rather than elevated. Corneal diseases including ulceration, edema from endothelial dysfunction, or dystrophy can create cloudiness resembling glaucoma-related changes. Dry eye syndrome causes chronic redness and ocular discharge that may be confused with glaucoma symptoms. Retinal diseases can cause vision loss without the pressure elevation characteristic of glaucoma. Thorough diagnostic evaluation including tonometry, gonioscopy, and detailed ocular examination differentiates these conditions from glaucoma.

Potential complications of chronic glaucoma extend beyond progressive vision loss to include painful and disfiguring changes that significantly impact quality of life. Corneal ulceration may develop in enlarged eyes where the eyelids cannot adequately protect and lubricate the exposed corneal surface. Lens luxation occurs when zonular fibers stretched by globe enlargement eventually fail, allowing the lens to fall forward or backward within the eye. Phthisis bulbi, or shrinkage of the eye, may occur in end-stage cases where chronic damage leads to ciliary body dysfunction and decreased fluid production. These complications often necessitate surgical intervention, including enucleation in cases where comfort cannot be maintained through other means. Understanding potential complications helps owners prepare for the possible progression of their dog's condition and make timely decisions about treatment escalation.